Temporal trends of kidney cancer incidence and mortality from 1990 to 2016 and projections to 2030
| Autor: | Wei Zhang, Shuhui Xin, Jiancheng Pan, Xinyu Zhang, Guiting Lin, Ying Gao, Xiaodong Zhou, Yuanjie Niu, Zhongcheng Xin, Qiliang Cai, Dingrong Zhang, Jie Hou, Shu Li, Chenjie Xu, Xuemei Guo, Yegang Chen, Baoshuai Zhang, Fei Ma, Yaogang Wang, Zunke Xie |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
R software Bladder cancer business.industry Urology Uncertainty interval Mortality rate Incidence (epidemiology) medicine.disease 03 medical and health sciences 0302 clinical medicine Reproductive Medicine 030220 oncology & carcinogenesis Epidemiology medicine Original Article 030212 general & internal medicine business Mortality trends Kidney cancer Demography |
| Zdroj: | Transl Androl Urol |
| ISSN: | 2223-4691 |
| Popis: | Background Bladder cancer is a leading cause of cancer-related deaths all over the world. Epidemiological studies of bladder cancer are therefore crucial for policy making. This study was carried out to describe the characteristics of changes in the incidence and mortality of bladder cancer from 1990 to 2016 by age group, gender, geographical region, and sociodemographic index (SDI) and to simultaneously project future trends up to 2030. Methods Incidence and mortality trends in bladder cancer from 1990 to 2016 were described based on data and methodologies from the Global Burden of Disease (GBD) Study. The data also allowed the future trends of bladder cancer incidence and mortality to be predicted by ARIMA model. Trends were analyzed by age group, gender, and SDI. Projections to 2030 were sub-analyzed by SDI countries. R software (x64 version 3.5.1), SAS (version 9.3), and SPSS (version 22.0) were used throughout the process. Results Globally, in 2016, there were 437,442 [95% uncertainty interval (UI), 426,709-447,912] new bladder cancer cases and 186,199 (95% UI, 180,453-191,686) bladder cancer-associated deaths. Between 1990 and 2016, changes in the age-standardized incidence rate (ASIR) of bladder cancer decreased by 5.91% from 7.11 (95% UI, 6.93-7.27) in 1990 to 6.69 (95% UI, 6.52-6.85) in 2016. The age-standardized death rate (ASDR) decreased from 3.58 (95% UI, 3.49-3.68) to 2.94 (95% UI, 2.85-3.03) over the same period of time. In future, the greatest occurrence of bladder cancer will be in high SDI countries, followed by high-middle SDI countries. Moreover, bladder cancer incidence rates may increase substantially in middle SDI countries, while the incidence rates will remain relatively stable for men and women in other SDI countries. From 2017 to 2030, bladder cancer deaths will continue to increase in low SDI countries, while deaths in other SDI countries will continue to decrease. Conclusions There was a regional difference in the incidence and mortality trends of bladder cancer between 1990 and 2016. Overall, the situation is not optimistic. From 2017 to 2030, the incidence of bladder cancer will continue to rise, especially in high and high-middle SDI countries, where decision-makers should propose appropriate policies on the screening and prevention of bladder cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|